{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:43:10Z","timestamp":1790476990971,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Variants of triggering receptor expressed on myeloid cells 2 (TREM2) are associated with an increased incidence of Alzheimer\u2019s disease, as well as other neurodegenerative disorders. TREM2 is glycosylated in vitro and in vivo, but the significance of the modification is unknown. We previously established a sensitive and specific reporter cell model involving cultured Jurkat cells stably expressing a luciferase reporter gene and a gene encoding a TREM2DAP12 fusion protein to monitor TREM2-dependent signalling. In the present study, we prepared modified reporter cells to investigate the role of the N-glycans at N20 and N79. We show that the N-glycans at N79 have a requisite role in translocation of TREM2 to the cell surface, while the N-glycans at both N20 and N79 have a critical role in intracellular signal transduction. Our results indicate that structural changes to the TREM2 N-glycans may cause microglial dysfunction that contributes to the pathogenesis of neurodegenerative disorders and that maintaining the integrity of TREM2 N-glycosylation and the responsible glycosyltransferases may be a novel therapeutic strategy to treat these disorders.<\/jats:p>","DOI":"10.1093\/jb\/mvac073","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T12:54:49Z","timestamp":1662641689000},"page":"347-353","source":"Crossref","is-referenced-by-count":35,"title":["The role of TREM2 N-glycans in trafficking to the cell surface and signal transduction of TREM2"],"prefix":"10.1093","volume":"172","author":[{"given":"Keiro","family":"Shirotani","sequence":"first","affiliation":[{"name":"Nagasaki University Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, , Nagasaki 852-8521, Japan"},{"name":"Nagasaki University Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, , Nagasaki 852-8521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hatta","sequence":"additional","affiliation":[{"name":"Nagasaki University Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, , Nagasaki 852-8521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Wakita","sequence":"additional","affiliation":[{"name":"Nagasaki University Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, , Nagasaki 852-8521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Nagasaki University Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, , Nagasaki 852-8521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Iwata","sequence":"additional","affiliation":[{"name":"Nagasaki University Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, , Nagasaki 852-8521, Japan"},{"name":"Nagasaki University Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, , Nagasaki 852-8521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"2022120612534739100_ref1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"2022120612534739100_ref2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"2022120612534739100_ref3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"2022120612534739100_ref4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"UKPMC funders group author manuscript and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"2022120612534739100_ref5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"2022120612534739100_ref6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"2022120612534739100_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"2022120612534739100_ref8","doi-asserted-by":"crossref","first-page":"934.e7","DOI":"10.1016\/j.neurobiolaging.2013.09.017","article-title":"Heterozygous TREM2 mutations in frontotemporal dementia","volume":"35","author":"Borroni","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"2022120612534739100_ref9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","article-title":"TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis","volume":"71","author":"Cady","year":"2014","journal-title":"JAMA Neurol."},{"key":"2022120612534739100_ref10","first-page":"78","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"Arch. Neurol."},{"key":"2022120612534739100_ref11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","article-title":"Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype","volume":"71","author":"Paloneva","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"2022120612534739100_ref12","doi-asserted-by":"crossref","first-page":"E194","DOI":"10.1002\/humu.20836","article-title":"Mutations in TREM2 lead to pure early-onset dementia without bone cysts","volume":"29","author":"Chouery","year":"2008","journal-title":"Hum. Mutat."},{"key":"2022120612534739100_ref13","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7176","article-title":"Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques","volume":"6","author":"Condello","year":"2015","journal-title":"Nat. Commun."},{"key":"2022120612534739100_ref14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J. Exp. Med."},{"key":"2022120612534739100_ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-9-20","article-title":"Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2","volume":"9","author":"Ulrich","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"2022120612534739100_ref16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20151948","article-title":"TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques","volume":"213","author":"Wang","year":"2016","journal-title":"J. Exp. Med."},{"key":"2022120612534739100_ref17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20142322","article-title":"TREM2 deficiency eliminates TREM2 + inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models","volume":"212","author":"Jay","year":"2015","journal-title":"J. Exp. Med."},{"key":"2022120612534739100_ref18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"2022120612534739100_ref19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.15252\/embr.201743922","article-title":"TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury","volume":"18","author":"Mazaheri","year":"2017","journal-title":"EMBO Rep."},{"key":"2022120612534739100_ref20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1523\/JNEUROSCI.2110-16.2016","article-title":"Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer\u2019s disease","volume":"37","author":"Jay","year":"2017","journal-title":"J. Neurosci."},{"key":"2022120612534739100_ref21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","article-title":"The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity","volume":"48","author":"Filipello","year":"2018","journal-title":"Immunity"},{"key":"2022120612534739100_ref22","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"2022120612534739100_ref23","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/glia.23953","article-title":"A reporter cell system for the triggering receptor expressed on myeloid cells 2 reveals differential effects of disease-associated variants on receptor signaling and activation by antibodies against the stalk region","volume":"69","author":"Ibach","year":"2021","journal-title":"Glia"},{"key":"2022120612534739100_ref24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/tra.12264","article-title":"Disease-associated mutations of TREM2 alter the processing of N-linked oligosaccharides in the Golgi apparatus","volume":"16","author":"Park","year":"2015","journal-title":"Traffic"},{"key":"2022120612534739100_ref25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-016-0367-7","article-title":"Rare TREM2 variants associated with Alzheimer\u2019s disease display reduced cell surface expression","volume":"4","author":"Sirkis","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"2022120612534739100_ref26","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.stemcr.2018.03.003","article-title":"Functional studies of missense TREM2 mutations in human stem cell-derived microglia","volume":"10","author":"Brownjohn","year":"2018","journal-title":"Stem Cell Rep."},{"key":"2022120612534739100_ref27","first-page":"1","article-title":"Siglec ligands","volume":"10","author":"Gonzalez-Gil","year":"2021","journal-title":"Cell"},{"key":"2022120612534739100_ref28","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1091\/mbc.e17-06-0423","article-title":"Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER-Golgi intermediate compartment","volume":"28","author":"Sirkis","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"2022120612534739100_ref29","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014352","article-title":"Mek1\/2 activity modulates trem2 cell surface recruitment","volume":"296","author":"Schapansky","year":"2021","journal-title":"J. Biol. Chem."},{"key":"2022120612534739100_ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-43535-6","article-title":"Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells","volume":"9","author":"Shirotani","year":"2019","journal-title":"Sci. Rep."},{"key":"2022120612534739100_ref31","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","article-title":"Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes","volume":"164","author":"Bouchon","year":"2000","journal-title":"J. Immunol."},{"key":"2022120612534739100_ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.20391","article-title":"Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms","volume":"5","author":"Kober","year":"2016","journal-title":"eLife"},{"key":"2022120612534739100_ref33","doi-asserted-by":"crossref","first-page":"12634","DOI":"10.1074\/jbc.RA118.002352","article-title":"Molecular basis for the loss-of-function effects of the Alzheimer\u2019s disease-associated R47H variant of the immune receptor TREM2","volume":"293","author":"Sudom","year":"2018","journal-title":"J. Biol. Chem."},{"key":"2022120612534739100_ref34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/glycob\/cwu033","article-title":"Structural change of N-glycan exposes hydrophobic surface of human transferrin","volume":"24","author":"Nagae","year":"2014","journal-title":"Glycobiology"},{"key":"2022120612534739100_ref35","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1111\/febs.15330","article-title":"Calnexin cycle\u2014structural features of the ER chaperone system","volume":"287","author":"Kozlov","year":"2020","journal-title":"FEBS J."},{"key":"2022120612534739100_ref36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129812","article-title":"Mechanisms of productive folding and endoplasmic reticulum-associated degradation of glycoproteins and non-glycoproteins","volume":"1865","author":"Ninagawa","year":"2021","journal-title":"Biochim. Biophys. Acta\u2014Gen. Subj."},{"key":"2022120612534739100_ref37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nbt799","article-title":"Enhancement of therapeutic protein in vivo activities through glycoengineering","volume":"21","author":"Elliott","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"2022120612534739100_ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"2022120612534739100_ref39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"2022120612534739100_ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology","volume":"14","author":"Su\u00e1rez-Calvet","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"2022120612534739100_ref41","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.neurobiolaging.2011.02.023","article-title":"A unique N-glycan on human transferrin in CSF: A possible biomarker for iNPH","volume":"33","author":"Futakawa","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"2022120612534739100_ref42","article-title":"High throughput ELISAs to measure a unique glycan on transferrin in cerebrospinal fluid: A possible extension toward Alzheimer\u2019s disease biomarker development","volume":"2011","author":"Shirotani","year":"2011","journal-title":"Int. J. Alzheimers Dis."}],"container-title":["The Journal of Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jb\/advance-article-pdf\/doi\/10.1093\/jb\/mvac073\/46347136\/mvac073.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jb\/article-pdf\/172\/6\/347\/47617066\/mvac073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jb\/article-pdf\/172\/6\/347\/47617066\/mvac073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:36:23Z","timestamp":1670369783000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jb\/article\/172\/6\/347\/6696348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,9,12]]},"published-print":{"date-parts":[[2022,12,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jb\/mvac073","relation":{},"ISSN":["0021-924X","1756-2651"],"issn-type":[{"value":"0021-924X","type":"print"},{"value":"1756-2651","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,9,12]]}}}